Specialist nurses in multidisciplinary prostate cancer teams

We often hear — from patients themselves and also from spouses and partners — about what they see as a failure of some physicians to address the problems that they want to discuss … READ MORE …

Less treatment regret with SBRT, and when patients are fully informed

There is growing recognition that the patient’s satisfaction or regret with his treatment decision is more than just a matter of whether he is happy with the oncological outcome. Satisfaction/regret is the product of many variables, including how well he understood his options, his interactions with his doctors, the side effects he suffered and when he suffered them, his expectations about the side effects of treatment, and cultural factors. … READ MORE …

Results of the PCaI prostate cancer patient “value” survey

Earlier this year, in late May and early June, Prostate Cancer International (PCaI) conducted what we have described as a very primitive pilot survey on prostate cancer patients’ perceptions of “value” in the management of this disease. … READ MORE …

Communication and value in the management of prostate cancer

When your sitemaster speaks to the assembled audience  at the annual meeting of ASTRO this coming Sunday, one point he intends to make relates to the importance and value of clear, straightforward, high-quality communication between physicians and patients. … READ MORE …

The role of the digital rectal examination in prostate cancer today

The question of whether digital rectal examinations (DREs) retain value in testing men for risk for prostate cancer (individual “screening”) has been controversial for many years now. Some men flatly refuse to have DREs for socio-cultural reasons. Others will put up with them, but they don’t like the idea. This is utterly unsurprising. … READ MORE …

Defining value in the management of prostate cancer

Many years ago, among his other famous quotations on the subject of prostate cancer, Willet Whitmore, considered by many to be the “father” of urologic oncology, stated the following: … READ MORE …

Nearly 600 responses already to “value” survey in management of prostate cancer

We have already received just under 600 responses to this survey in the first 2 weeks, but the survey will be accessible for a few more days before we take it down and start to analyze the data. … READ MORE …